Human papillomavirus DNA in tumor-free regional lymph nodes: A potential prognostic marker in cervical carcinoma

Cancer Journal from Scientific American

Volumn 2, Issue 1, 1996, Pages 28-34

  Ikenberg, Hans ^a,b   Wiegering, Irena ^a   Pfisterer, Jacobus ^a   Kiechle Schwarz, Marion ^a   Schmitt, Beate ^a   Sauerbrei, Willi ^a   Pfleiderer, Albrecht ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Archival tissue; Cervical carcinoma; Human papillomavirus; Lymph nodes; Micrometastasis; PCR; Prognosis

Indexed keywords

VIRUS DNA;

ADULT; ARTICLE; FEMALE; HUMAN; ISOLATION AND PURIFICATION; LYMPH NODE; LYMPH NODE METASTASIS; MALE; MIDDLE AGED; MORTALITY; PAPILLOMA VIRUS; PATHOLOGY; PILOT STUDY; POLYMERASE CHAIN REACTION; PROGNOSIS; UTERINE CERVIX TUMOR; VIROLOGY; VIRUS INFECTION;

ADULT; DNA, VIRAL; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PAPILLOMAVIRIDAE; PILOT PROJECTS; POLYMERASE CHAIN REACTION; PROGNOSIS; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

EID: 0004444828     PISSN: 10814442     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Burke TW, Hoskins WJ, Heller PB, Bibro MC, Weiser EB, Park RC. Prognostic factors associated with radical hysterectomy failure. Gynecol Oncol 1987;26:153-159.
2. Delgado G, Bundy B, Zaino R, Sevin B, Creasman WT, Major F. Prospective surgical-pathological study on disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. Gynecol Oncol 1990;38:352-357.
3. Smiley LM, Burke TW, Silva EG, Morris M, Gershenson DM, Wharton JT. Prognostic factors in stage IB squamous cervical cancer patients with low risk for recurrence. Obstet Gynecol 1991;77:271-275.
4. International (Ludwig) Breast Cancer Study Group. Prognostic importance of occult axillary lymph node micrometastases assessed by two special techniques: re-evaluation with longer follow-up. Lancet 1990;335:1565-1568.
5. De Mascarel I, Bonichon F, Coindre JM, Trojani M. Prognostic significance of breast cancer axillary lymph node micrometastases assessed by two special techniques: re-evaluation with longer follow up. Br J Cancer 1992;66:523-527.
6. Clayton F, Hopkins L. Pathologic correlates of prognosis in lymph node-positive breast carcinomas. Cancer 1993;71:1780-1790.
7. Pantel K, Izbicki JR, Anstwurm M et al. Immunocytological detection of bone marrow micrometastasis in operable non-small cell lung cancer. Cancer Res 1993;53:1027-1031.
8. Dürst M, Gissmann L, Ikenberg H, zur Hausen H. A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc Natl Acad Sci USA 1983;80:3812-3815.
9. zur Hausen H. Molecular pathogenesis of cancer of the cervix and its causation by specific HPV types. Curr Top Microbiol Immunol 1994;186:131-156.
10. Lancaster WD, Castellano C, Santos C, Delgado G, Kurman RJ, Jenson AB. Human papillomavirus DNA in cervical carcinoma from primary and metastatic sites. Am J Obstet Gynecol 1986;154:115-118.
11. Fuchs P, Girardi F, Pfister H. Human papillomavirus 16 DNA in cervical cancers and in lymph nodes of cervical cancer patients: a diagnostic marker for early metastases? Int J Cancer 1989;43:41-44.
12. Czegledy J, Poka R, Veress G, Gergely L. Amplification of human papillomavirus type 16 transforming genes from cervical cancer biopsies and lymph nodes of hungarian patients. J Clin Microbiol 1992;30:233-236.
13. Nawa A, Nishiyama Y, Kikkawa F et al. Detection of human papillomaviruses from histologically normal lymph nodes of Japanese cervical cancer patients by nested polymerase chain-reaction assay. Int J Cancer 1993;53:932-937.
14. Ikenberg H, Sauerbrei S, Schottmüller, U, Spitz C, Pfleiderer A. Human papillomavirus DNA in cervical carcinoma - correlation with clinical data and influence on prognosis. Int J Cancer 1994;59:322-326.
15. Young LS, Bevan JS, Johnson MA et al. The polymerase chain reaction: a new epidemiological tool for investigating cervical human papillomavirus infection. Br Med J 1989;289:14-18.
16. Anceschi M, Fallcinelli C, Pieretti M, Cosmi E. Multiple primer pairs polymerase chain reaction for the detection of human papillomavirus types. J Virol Meth 1990;28:59-66.
17. Saiki R, Scharf S, Faloona F et al. Enzymatic amplification of β-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 1985;230:1350-1354.
18. Mansi JL, Berger U, Easton D et al. Micrometastases in bone marrow in patients with primary breast cancer: evaluation as an early predictor of bone metastases. Br Med J 1987;295:1093-1096.
19. Cote RJ, Rosen PP, Lesser ML, Old LJ, Osborne MP. Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases. J Clin Oncol 1991;9:1749-1756.
20. Schlimok G, Funke I, Pantel K et al. Micrometastatic tumor cells in bone marrow of patients with gastric cancer: methodological aspects of detection and prognostic significance. Eur J Cancer 1991;27:1461-1465.
21. Lindemann F, Schlimok G, Dirschedl P, Witte J, Riethmüller G. Prognostic significance of micrometastatic tumour cells in bone marrow of colorectal cancer patients. Lancet 1992;340:685-689.
22. Lee M, Chang K, Freireich EJ et al. Detection of minimal residual bcr/abl transcripts by a modified polymerase chain reaction. Blood 1988;72:893-897.
23. Yamada M, Wasserman R, Lange B, Reichard B, Womer R, Rovera G. Minimal residual disease in childhood B-lineage lymphoblastic leukemia: persistence of leucemic cells during the first 18 months of treatment. N Engl J Med 1990;232:448-455.
24. Smith B, Selby P, Southgate J, Pittman K, Bradley C, Blair G. Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction. Lancet 1991;338:1227-1229.
25. Naito H, Kuzumaki N, Uchino J et al. Detection of tyrosine hydroxylase mRNA and minimal neuroblastoma cells by the reverse transcription-polymerase chain reaction. Eur J Cancer 1991;27:762-765.
26. Mattano LA, Moss TJ, Emerson SG. Sensitive detection of rare circulating neuroblastoma cells by the reverse-transcriptase polymerase chain reaction. Cancer Res 1992;52:4701-4705.
27. Moreno JG, Croce CM, Fischer R et al. Detection of hematogenous micrometastasis in patients with prostate cancer. Cancer Res 1992;52:6110-6112.
28. Deguchi T, Tatsuo D, Ehara H et al. Detection of micrometastatic prostate cancer cells in lymph nodes by reverse transcriptase-polymerase chain reaction. Cancer Res 1993;53:5350-5354.
29. Hayashi N, Arakawa H, Nagase H et al. Genetic diagnosis identifies occult lymph node metastases undetectable by the histopathologic method. Cancer Res 1994;54:3853-3856.
30. Schoenfeld A, Luqmani Q, Smith D et al. Detection of breast cancer micrometastases in axillary lymph nodes by using polymerase chain reaction. Cancer Res 1994;54:2986-2900.
31. Jen J, Kim H, Piantadosi S et al. Allelic loss of chromosome 18q and prognosis in colorectal cancer. N Engl J Med 1994;331:213-221.
32. Busby-Earle RMC, Steel CM, Bird CC. Cervical carcinoma: low frequency of allele loss at loci implicated in other common malignancies. Br J Cancer 1993;67:71-75.
33. Ikenberg H, Teufel G, Schmitt B, Kommoss F, Stanimirovic B, Pfleiderer A. Human papillomavirus DNA in distant metastases of cervical cancer. Gynecol Oncol 1993;48:56-60.
34. Ikenberg H, Spitz C, Schmitt B, Pfisterer J, Aisslinger U, Pfleiderer A. Human papillomavirus DNA in locally recurrent cervical cancer. Gynecol Oncol 1994;52:332-336.
35. Schneider A, Meinhardt G, Kirchmayr R, Schneider V. Prevalence of human papillomavirus genomes in tissues from the lower genital tract as detected by molecular in situ hybridization. Int J Gynecol Pathol 1991;10:1-14.
36. Nuovo GJ, MacConnell P, Forde A, Delvenne P. Detection of human papillomavirus DNA in formalin-fixed tissues by in situ hybridization after amplification by polymerase chain reaction. Am J Pathol 1991;139:847-854.